356 related articles for article (PubMed ID: 24802387)
1. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation.
Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY
FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387
[TBL] [Abstract][Full Text] [Related]
2. Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions.
Wang XY; Guo YQ; Shao XX; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2014 Sep; 558():127-32. PubMed ID: 25043977
[TBL] [Abstract][Full Text] [Related]
3. The highly conserved negatively charged Glu141 and Asp145 of the G-protein-coupled receptor RXFP3 interact with the highly conserved positively charged arginine residues of relaxin-3.
Zhang WJ; Wang XY; Guo YQ; Luo X; Gao XJ; Shao XX; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2014 May; 46(5):1393-402. PubMed ID: 24615237
[TBL] [Abstract][Full Text] [Related]
4. Identification of hydrophobic interactions between relaxin-3 and its receptor RXFP3: implication for a conformational change in the B-chain C-terminus during receptor binding.
Hu MJ; Shao XX; Wang JH; Wei D; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2016 Sep; 48(9):2227-36. PubMed ID: 27193232
[TBL] [Abstract][Full Text] [Related]
5. Exploring electrostatic interactions of relaxin family peptide receptor 3 and 4 with ligands using a NanoBiT-based binding assay.
Wang JH; Nie WH; Shao XX; Li HZ; Hu MJ; Liu YL; Xu ZG; Guo ZY
Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):776-786. PubMed ID: 30684458
[TBL] [Abstract][Full Text] [Related]
6. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
7. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
[TBL] [Abstract][Full Text] [Related]
8. Exploring receptor selectivity of the chimeric relaxin family peptide R3/I5 by incorporating unnatural amino acids.
Wang JH; Hu MJ; Zhang L; Shao XX; Lv CH; Liu YL; Xu ZG; Guo ZY
Biochimie; 2018 Nov; 154():77-85. PubMed ID: 30102931
[TBL] [Abstract][Full Text] [Related]
9. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
[TBL] [Abstract][Full Text] [Related]
10. Mechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4.
Hu MJ; Shao XX; Wang JH; Wei D; Guo YQ; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2016 Jul; 6():29648. PubMed ID: 27404393
[TBL] [Abstract][Full Text] [Related]
11. Relaxin family peptides and their receptors.
Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ
Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914
[TBL] [Abstract][Full Text] [Related]
12. Rapid preparation of bioluminescent tracers for relaxin family peptides using sortase-catalysed ligation.
Wang JH; Shao XX; Hu MJ; Wei D; Nie WH; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2017 Sep; 49(9):1611-1617. PubMed ID: 28631012
[TBL] [Abstract][Full Text] [Related]
13. The complex binding mode of the peptide hormone H2 relaxin to its receptor RXFP1.
Sethi A; Bruell S; Patil N; Hossain MA; Scott DJ; Petrie EJ; Bathgate RAD; Gooley PR
Nat Commun; 2016 Apr; 7():11344. PubMed ID: 27088579
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel ligand binding assay for relaxin family peptide receptor 3 and 4 using NanoLuc complementation.
Hu MJ; Shao XX; Li HZ; Nie WH; Wang JH; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2018 Aug; 50(8):1111-1119. PubMed ID: 29770870
[TBL] [Abstract][Full Text] [Related]
15. Site-specific DOTA/europium-labeling of recombinant human relaxin-3 for receptor-ligand interaction studies.
Zhang WJ; Luo X; Liu YL; Shao XX; Wade JD; Bathgate RA; Guo ZY
Amino Acids; 2012 Aug; 43(2):983-92. PubMed ID: 22187146
[TBL] [Abstract][Full Text] [Related]
16. Interaction mechanism of insulin-like peptide 5 with relaxin family peptide receptor 4.
Hu MJ; Wei D; Shao XX; Wang JH; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2017 Apr; 619():27-34. PubMed ID: 28274616
[TBL] [Abstract][Full Text] [Related]
17. A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.
Zhang WJ; Jiang Q; Wang XY; Song G; Shao XX; Guo ZY
J Pept Sci; 2013 Jun; 19(6):350-4. PubMed ID: 23526726
[TBL] [Abstract][Full Text] [Related]
18. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
19. Functionality of an absolutely conserved glycine residue in the chimeric relaxin family peptide R3/I5.
Wang JH; Shao XX; Hu MJ; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2019 Apr; 51(4):619-626. PubMed ID: 30604098
[TBL] [Abstract][Full Text] [Related]
20. Membrane receptors: structure and function of the relaxin family peptide receptors.
Kong RC; Shilling PJ; Lobb DK; Gooley PR; Bathgate RA
Mol Cell Endocrinol; 2010 May; 320(1-2):1-15. PubMed ID: 20138959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]